The 10t,12c isomer of conjugated linoleic acid inhibits fatty acid synthase expression and enzyme activity in human breast, colon, and prostate cancer cells

Nutrition and Cancer

Volumn 62, Issue 1, 2010, Pages 116-121

  Lau, Dominic S Y ^a   Archer, Michael C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED LINOLEIC ACID; FATTY ACID SYNTHASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG INHIBITION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOMER; PROSTATE CANCER; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENZYME INHIBITORS; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION; HT29 CELLS; HUMANS; ISOMERISM; LINOLEIC ACIDS, CONJUGATED; MALE; PROSTATIC NEOPLASMS;

EID: 74249107372     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580903191536     Document Type: Article

References (50)

1. Wakil SJ: Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28, 4523-4530, 1989.
2. Alo PL,Visca P,Trombetta G, Mangoni A, LentiL, et al.: Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas. Tumori 85, 35-40, 1999.
3. Epstein JI, Carmichael M, and Partin AW: OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 45, 81-86, 1995.
4. Gansler TS, Hardman W 3rd, Hunt DA, Schaffel S, and Hennigar RA: Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum Pathol 28, 686-692, 1997.
5. Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16, 202-208, 2000.
6. Kusakabe T, Nashimoto A, Honma K, and Suzuki T: Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 40, 71-79, 2002.
7. Milgraum LZ, Witters LA, Pasternack GR, and Kuhajda FP: Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 3, 2115-2120, 1997.
8. Piyathilake CJ, Frost AR, Manne U, Bell WC, Weiss H, et al.: The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 31, 1068-1073, 2000.
9. Pizer ES, Lax SF, Kuhajda FP, Pasternack GR, and Kurman RJ: Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors. Cancer 83, 528-537, 1998.
10. Shurbaji MS, Kalbfleisch JH, and Thurmond TS: Immunohistochemical detection of a fatty acid synthase (OA-519) as a predictor of progression of prostate cancer. Hum Pathol 27, 917-921, 1996.
11. Jensen V, Ladekarl M, Holm-Nielsen P, Melsen F, and Soerensen FB: The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer. J Pathol 176, 343-352, 1995.
12. Kridel SJ, Axelrod F, Rozenkrantz N, and Smith JW: Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res 64, 2070-2075, 2004.
13. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, et al.: Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 91, 6379-6383, 1994.
14. Liu B, Wang Y, Fillgrove KL, and Anderson VE: Triclosan inhibits enoylreductase of type I fatty acid synthase in vitro and is cytotoxic toMCF-7 and SKBr-3 breast cancer cells. Cancer Chemother Pharmacol 49, 187-193, 2002.
15. Pizer ES, Chrest FJ, DiGiuseppe JA, and Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58, 4611-4615, 1998.
16. Pizer ES, Wood FD, Heine HS, Romantsev FE, Pasternack GR, et al.: Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res 56, 1189-1193, 1996.
17. Pizer ES, Wood FD, Pasternack GR, and Kuhajda FP: Fatty acid synthase (FAS): a target for cytotoxic antimetabolites in HL60 promyelocytic leukemia cells. Cancer Res 56, 745-751, 1996.
18. Pariza MW, Park Y, and Cook ME: Mechanisms of action of conjugated linoleic acid: evidence and speculation. Proc Soc Exp Biol Med 223, 8-13, 2000.
19. Ma DW, Wierzbicki AA, Field CJ, and Clandinin MT: Conjugated linoleic acid in Canadian dairy and beef products. J Agric Food Chem 47, 1956-1960, 1999.
20. Ha YL, Storkson J, and Pariza MW: Inhibition of benzo(a)pyrene-induced mouse forestomach neoplasia by conjugated dienoic derivatives of linoleic acid. Cancer Res 50, 1097-1101, 1990.
21. ParizaMW, Ashoor SH, Chu FS, and Lund DB: Effects of temperature and time on mutagen formation in pan-fried hamburger. Cancer Lett 7, 63-69, 1979.
22. Park HS, Ryu JH, Ha YL, and Park JH: Dietary conjugated linoleic acid (CLA) induces apoptosis of colonic mucosa in 1,2-dimethylhydrazinetreated rats: a possible mechanism of the anticarcinogenic effect by CLA. Br J Nutr 86, 549-555, 2001.
23. Visonneau S, Cesano A, Tepper SA, Scimeca JA, Santoli D, et al.: Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res 17, 969-973, 1997.
24. Cho HJ, Kim WK, Kim EJ, Jung KC, Park S, et al.: Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 284, G996-G1005, 2003.
25. Majumder B,Wahle KW, Moir S, Schofield A, Choe SN, et al.: Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. Faseb J 16, 1447-1449, 2002.
26. Palombo JD, Ganguly A, Bistrian BR, and Menard MP: The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett 177, 163-172, 2002.
27. Park HS, Chun CS, Kim S, Ha YL, and Park JH: Dietary trans-10, cis-12 and cis-9,trans-11 conjugated linoleic acids induce apoptosis in the colonic mucosa of rats treated with 1,2-dimethylhydrazine. J Med Food 9, 22-27, 2006.
28. Kim EJ, Holthuizen PE, Park HS, Ha YL, Jung KC, et al.: Trans-10,cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth. Am J Physiol Gastrointest Liver Physiol 283, G357-G367, 2002.
29. Kim EJ, Kang IJ, Cho HJ, Kim WK, Ha YL, et al.: Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells. J Nutr 133, 2675-2681, 2003.
30. Cho HJ, KimWK, Jung JI, Kim EJ, Lim SS, et al.: Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells. World J Gastroenterol 11, 5142-5150, 2005.
31. Kemp MQ, Jeffy BD, and Romagnolo DF: Conjugated linoleic acid inhibits cell proliferation through a p53-dependent mechanism: effects on the expression of G1-restriction points in breast and colon cancer cells. J Nutr 133, 3670-3677, 2003.
32. Song HJ, Sneddon AA, Barker PA, Bestwick C, Choe SN, et al.: Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells. Nutr Cancer 49, 100-108, 2004.
33. Igarashi M and Miyazawa T: The growth inhibitory effect of conjugated linoleic acid on a human hepatoma cell line, HepG2, is induced by a change in fatty acid metabolism, but not the facilitation of lipid peroxidation in the cells. Biochim Biophys Acta 1530, 162-171, 2001.
34. Ma DW, Field CJ, and Clandinin MT: An enriched mixture of trans-10,cis-12-CLA inhibits linoleic acid metabolism and PGE2 synthesis in MDAMB-231 cells. Nutr Cancer 44, 203-212, 2002.
35. Zulet MA, Marti A, Parra MD, and Martinez JA: Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health. J Physiol Biochem 61, 483-494, 2005.
36. Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, et al.: Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 98, 19-22, 2002.
37. Thompson BJ, Stern A, and Smith S: Purification and properties of fatty acid synthetase from a human breast cell line. Biochim Biophys Acta 662, 125-130, 1981.
38. Mosley EE, McGuire MK, Williams JE, and McGuire MA: Cis-9, trans-11 conjugated linoleic acid is synthesized from vaccenic acid in lactating women. J Nutr 136, 2297-2301, 2006.
39. Ohta A, Mayo MC, Kramer N, and Lands WE: Rapid analysis of fatty acids in plasma lipids. Lipids 25, 742-747, 1990.
40. Miglietta A, Bozzo F, Bocca C, Gabriel L, Trombetta A, et al.: Conjugated linoleic acid induces apoptosis inMDA-MB-231 breast cancer cells through ERK/MAPK signalling and mitochondrial pathway. Cancer Lett 234, 149-157, 2006.
41. Choi Y, Kim YC, Han YB, Park Y, Pariza MW, et al.: The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. J Nutr 130, 1920-1924, 2000.
42. Lin X, Loor JJ, and Herbein JH: Trans10,cis12-18:2 is a more potent inhibitor of de novo fatty acid synthesis and desaturation than cis9,trans11-18:2 in the mammary gland of lactating mice. J Nutr 134, 1362-1368, 2004.
43. Park Y, Storkson JM, Albright KJ, Liu W, and Pariza MW: Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 34, 235-241, 1999.
44. Wang YM, Nagao K, Inoue N, Ujino Y, Shimada Y, et al.: Isomer-specific anti-obese and hypolipidemic properties of conjugated linoleic acid in obese OLETF rats. Biosci Biotechnol Biochem 70, 355-362, 2006.
45. Zabala A, Churruca I, Macarulla MT, Rodriguez VM, Fernandez-Quintela A, et al.: The trans-10,cis-12 isomer of conjugated linoleic acid reduces hepatic triacylglycerol content without affecting lipogenic enzymes in hamsters. Br J Nutr 92, 383-389, 2004.
46. Oku H, Wongtangtintharn S, Iwasaki H, and Toda T: Conjugated linoleic acid (CLA) inhibits fatty acid synthetase activity in vitro. Biosci Biotechnol Biochem 67, 1584-1586, 2003.
47. Fa M, Diana A, Carta G, Cordeddu L, Melis MP, et al.: Incorporation and metabolism of c9,t11 and t10,c12 conjugated linoleic acid (CLA) isomers in rat brain. Biochim Biophys Acta 1736, 61-66, 2005.
48. Banni S, Petroni A, Blasevich M, Carta G, Cordeddu L, et al.: Conjugated linoleic acids (CLA) as precursors of a distinct family of PUFA. Lipids 39, 1143-1146, 2004.
49. Donnelly C, Olsen AM, Lewis LD, Eisenberg BL, Eastman A, et al.: Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and inpairs the growth of human breast cancer and liposarcoma cells. Nutr Cancer 61, 114-122, 2009.
50. Lu S and Archer MC: Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer. Carcinogenesis 26, 153-157, 2005.